Parteck® SLC 500

Description

Parteck® SLC 500 excipient is part of the Parteck® range of functional excipients developed specifically for solid dose applications. It is an innovative silica drug carrier well-suitable for solubility enhancement of poorly water-soluble active pharmaceutical ingredients. Due to its unique surface structure, it stabilizes the amorphous state of the API.

Parteck® SLC – Enhancing Drug Solubility

Low solubility of your active pharmaceutical ingredient (API) is often the cause of poor bioavailability. To improve your formulation we have developed Parteck® SLC, an innovative silica drug carrier that was awarded the silver prize at the 2012 CPhI Pharma Awards. Parteck® SLC provides maximum load for maximum release, significantly increasing bioavailability of your API.

Benefits of Parteck® SLC:

• Enhances solubility of APIs
• Superior dissolution performance
• Unique pore structure and high surface area
• User-friendly particle properties
• Reliable supply chain and application support

Feasibility studies have proven Parteck® SLC’s outstanding performance both in vitro and in vivo. Parteck® SLC offers the opportunity to reformulate molecules and potentially extend the life cycle of a drug.

Our expert support team is here to help – from early development to production. We offer you feasibility studies on loading your API on the carrier Parteck® SLC, showing the dissolution performance and helping you with final tablet formulation.